About
About FACIT
Our Network
Leadership
Careers
Contact
Portfolio
Funds
Funds & Programs Overview
Prospects
Compass Rose
WeSEED
Falcons’ Fortunes
2026 Event Info & RSVP
Pitch Competition – apply
News
Search:
Contrast:
Normal
Contrast Setting
High
Text Size:
Portfolio Category:
Compass Rose
FACIT-18 | Fluorinov Pharma (acquired by Trillium Therapeutics)
October 5, 2021
–
FACIT-03 | DVS Sciences (acquired by Fluidigm)
October 5, 2021
–
FACIT-19 | OICR (Cellax)
October 5, 2021
–
FACIT-04 | Xagenic
October 5, 2021
–
FACIT-20 | Turnstone Biologics Inc. (acquired by Xoma Royalty)
October 5, 2021
–
FACIT-05 | DLVR Therapeutics
October 5, 2021
–
FACIT-25 | Ziliomics
October 5, 2021
–
FACIT-06 | UHN (TorCell Therapeutics, Dr. L. Zhang)
October 5, 2021
–
FACIT-28 | Fusion Pharmaceuticals Inc. (acquired by AstraZeneca)
October 5, 2021
–
FACIT-07 | Profound Medical
October 5, 2021
–
Posts navigation
«
1
2
3
4
»
recaptcha